tirzepatide shortage fda Removes from List Compounders protest as FDA removes

Invest New Drugs

The most common Zepbound side effects GLP-1 agonists like Zepbound partly work in the gut, which is why many of their potential side effects are gastrointestinal in nature

The review of this NDA is expected to be completed in the second quarter of 2025

& Zarnescu, O

As you will read further down, specialty and biosimilar drugs are driving revenue and the stack of assets that Cigna/Evernorth has built in this area is strong and well poised for future growth with the specialty drug explosion and some of the fuel provided to specialty drugs by the Inflation Reduction Act cap of out of pocket expenses

FAO Expert Consultation and Workshop on Protein Sources for the Animal Feed Industry